i-base

News

Pocket guides (March 2017)

NEW: pocket size leaflets based the longer i-Base guides – includes hepatitis C confection and UK guide to PrEP

Fit for purpose: antiretroviral treatment optimisation (Feb 2017)

Some ARVs have shown superior or non-inferior efficacy at reduced doses compared to existing recommended ones. These drugs offer improved durability and tolerability, higher bioavailability, lower pill burden, and the potential for fewer side effects. The ARVs are: dolutegravir (DTG), tenofovir alafenamide …

Early reports from CROI 2017

14 rapid reports from Seattle… new drugs, dolutegravir monotherapy studies stopped, paediatric formulations, PrEP failure case, good news from brain scans… more to follow…

November/December HTB now online

Post-US election issue: reports from Glasgow Congress and Research for Preventions meetings, global treatment, EACS guidelines, UK PrEP updates and more…

New: UK guide to PrEP (November 2016)

Using generic PrEP bought online – new guide for how to use PrEP safely, including options for dosing…

International Congress of Drug Therapy in HIV infection (Glasgow 2016), 23-26 October 2016

Introduction This year the biennial Glasgow conference was held from 23-26 October 2016. The meeting has a single-track programme making it easy to attend and follow the whole programme, often highlight important European research before it is presented at CROI, …

HIV Research for Prevention Conference (HIVR4P) 2016

First reports from this prevention conference being held in Chicago.

September/October HTB now online

PrEP safety, side effects of integrase inhibitors, HIV and children and global access to dolutegravir – reports from four meetings + other news including reduced dose maintenance studies…

July/August HTB now online

News from Durban on HIV prevention including TasP and PrEP, paediatrics, TB and cure research – plus news about PrEP in the UK…

Reports from AIDS 2016 and linked workshops

Reports from AIDS 2016 include PrEP and new drugs plus news from the pre-conference paediatric and TB workshops…

PROUD study closes leaving participants with no access to PrEP

Simon Collins, HIV i-Base On 29 July 2016, the PROUD study website announced that the study will close without being able to continue to provide participants with oral PrEP. [1] The press release blames NHS England for cancelling the previous …

CERO: No se registró ningún caso de transmisión del VIH vinculado a la pareja en el estudio PARTNER, tras 58.000 relaciones sexuales sin usar condón

Simon Collins, VIH i-Base Los resultados del estudio PARTNER publicados en coincidencia con la conferencia AIDS 2016, que se inaugura en Durban (Sudáfrica) la próxima semana, revelan el impacto del tratamiento antirretroviral en la drástica reducción de la transmisión del …

Preguntas y Respuestas sobre el estudio PARTNER: Cómo interpretar el resultado de cero transmisiones

El siguiente cuestionario está relacionado con el estudio PARTNER que fue publicado en la edición del 12 de julio de 2016 de Journal of the American Medical Association (JAMA), cuya versión completa está disponible de forma gratuita. A continuación se …

Q&A on the PARTNER study: how to interpret the zero transmission results

Full paper published in JAMA as open access article.

2016 pipeline report now online

Annual overview of HIV and TB pipeline research: paediatrics and adults

May/June HTB now online

NHS decision to block PrEP, reports from BHIVA, EASL, CROI and HIV and Women conferences, use of HPV vaccine – and remembering i-Base founder Paul Blanchard…

Activists convince Washington Post that Pfizer lowers prices: global action highlights fairer alternatives – this story has been removed!

Simon Collins, HIV i-Base The dominant market structure where pharmaceutical drug pricing blocks access to otherwise cheap-to-manufacture life-saving medicines from the people who most need them, was highlighted by international activists on Friday. This was a coordinated action linking community-based …

Sign-on for PrEP to be raised in Parliament

Sign on now… Approved in the US, France, Canada and South Africa. Public discussion banned by NHS England… access blocked in UK

March/April HTB now online

Dozens of studies from CROI 2016: PrEP, new HIV drugs, paediatric and access… plus STOP-PRESS news that NHS England blocks PrEP in the UK…

CROI 2016 – first reports: PrEP, new HIV drugs, cure and access

First reports from CROI in Boston: dozens of studies and an overview of other issues…

Post navigation